Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Non Operating Investment Income: 2010-2012

Historic Non Operating Investment Income for Northwest Biotherapeutics (NWBO) over the last 2 years, with Dec 2012 value amounting to $1.4 million.

  • Northwest Biotherapeutics' Non Operating Investment Income rose 97.85% to $1.4 million in Q4 2012 from the same period last year, while for Dec 2012 it was $2.0 million, marking a year-over-year increase of 170.05%. This contributed to the annual value of -$5.7 million for FY2016, which is N/A change from last year.
  • Northwest Biotherapeutics' Non Operating Investment Income amounted to $1.4 million in Q4 2012, which was up 3,851.43% from $35,000 recorded in Q3 2012.
  • Over the past 5 years, Northwest Biotherapeutics' Non Operating Investment Income peaked at $1.4 million during Q4 2012, and registered a low of -$161,000 during Q1 2011.
  • In the last 3 years, Northwest Biotherapeutics' Non Operating Investment Income had a median value of $200,000 in 2012 and averaged $305,333.
  • Per our database at Business Quant, Northwest Biotherapeutics' Non Operating Investment Income soared by 1,194.44% in 2011 and then crashed by 89.64% in 2012.
  • Quarterly analysis of 3 years shows Northwest Biotherapeutics' Non Operating Investment Income stood at $54,000 in 2010, then surged by 1,194.44% to $699,000 in 2011, then surged by 97.85% to $1.4 million in 2012.
  • Its last three reported values are $1.4 million in Q4 2012, $35,000 for Q3 2012, and $200,000 during Q2 2012.